Ingenia Therapeutics Inc. (KOSDAQ:950260)
South Korea · Delayed Price · Currency is KRW 23,600
+350 (1.51%)
At close: Oct 28, 2026
Ingenia Therapeutics Revenue
Ingenia Therapeutics had revenue of 7.42B KRW in the quarter ending June 30, 2026. This brings the company's total for the last twelve months to 7.42B. That makes Ingenia Therapeutics the 39,580th largest company in the world by revenue and 2,472nd in South Korea.
Revenue (ttm)
7.42B
Revenue Growth
n/a
P/S Ratio
157.28
Revenue / Employee
370.96M
Employees
20
Market Cap
1.17T
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | 3.53B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.